News
Media
All Videos
Medical World News
Podcasts
Weekly Recap
Cure Connections
Insights
News Network
NeurologyLive Peer Exchange
Medcast Podcasts
Medcast Videos
Peers & Perspectives
Roundtable Discussions
Conferences
Conference Coverage
Conference Listing
CME/CE
Partners
Publications
NeurologyLive
Bridging the Gaps
International Journal of MS Care
Resources
Disease Spotlight
Fellows' Corner
Future Leaders in Neurology
Giants of Multiple Sclerosis
Interactive Tools
Live Events
Neurology Resources
Sponsored
Virtual Events
Subscribe
Choose Specialty
Dementia and Alzheimer Disease
Epilepsy
Headache and Migraine
Headache and Migraine
MS and Demyelinating Disorders
MS and Demyelinating Disorders
MS and Demyelinating Disorders
MS and Demyelinating Disorders
Movement Disorders
Movement Disorders
Neuromuscular
Neuromuscular
Neuromuscular
Neuromuscular
Sleep Disorders
Sleep Disorders
Sleep Disorders
Stroke
Spotlight -
ATMRD 2024
Secondary Symptoms of Parkinson Disease
Choose Specialty
Dementia and Alzheimer Disease
Epilepsy
Headache and Migraine
Headache and Migraine
MS and Demyelinating Disorders
MS and Demyelinating Disorders
MS and Demyelinating Disorders
MS and Demyelinating Disorders
Movement Disorders
Movement Disorders
Neuromuscular
Neuromuscular
Neuromuscular
Neuromuscular
Sleep Disorders
Sleep Disorders
Sleep Disorders
Stroke
Spotlight
News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe
Advertisement
Gary Owens, MS
home
/
authors
/
gary-owens-ms
Associate director for gene therapy discovery at Precision Biosciences.
Articles
New content coming soon.
Latest Updated Articles
Published: July 22nd 2024
| Updated: July 24th 2024
A Comprehensive Program to Enhance Inpatient Care for Patients With Parkinson Disease
Published: June 24th 2024
| Updated: July 24th 2024
Advanced Therapeutic Options for Parkinson Disease and Essential Tremor: Anvi Gadani, MD
Published: March 1st 2024
| Updated: July 23rd 2024
Ozanimod's Consistent Efficacy in Long-Term Treatment for Multiple Sclerosis: Jeffrey Cohen, MD
Published: July 22nd 2024
| Updated: July 23rd 2024
Subcutaneous Immunoglobulin Shows Superiority Over IVIG in Treating CIDP, Meta-Analysis Shows
Published: July 22nd 2024
| Updated: July 23rd 2024
Early Biomarker Evaluation and Cognitive Stabilization in Alzheimer Treatment: Martin Tolar, MD, PhD
Published: July 6th 2024
| Updated: July 11th 2024
Synapse-Targeting Agent ALX-001 Ready for Phase 2 Following Early-Stage Progress